At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 5:14:58 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,079.5700
-18,865.8730
-14,692.1390
-12,365.6700
-3,240.2370
Investing Cash Flow
8,162.8100
10,222.6670
-14,774.8130
-94.2120
-20.8260
Financing Cash Flow
20,259.8360
12,641.3430
-78.7740
41,766.7750
10,486.9610
End Cash Position
11,646.7220
11,828.9700
7,342.4290
36,911.9520
7,504.2810
Income Tax Paid Supplemental Data
--
134.9620
2.7400
4.4690
4.5690
Capital Expenditure
-21.5670
-15.3580
-118.9530
-94.2120
-20.8260
Issuance of Capital Stock
20,459.8690
12,730.4100
--
42,629.9980
10,219.4240
Issuance of Debt
--
--
--
--
738.2820
Repayment of Debt
-90.6780
-89.0670
-78.7740
-21.9510
--
Free Cash Flow
-21,101.1370
-18,881.2310
-14,811.0920
-12,459.8820
-3,261.0630
12/31/2020 - 3/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COYA Coya Therapeutics, Inc.
5.24
+1.55%
INMB INmune Bio, Inc.
4.4000
-0.45%
ACTU Actuate Therapeutics, Inc. Common stock
6.77
-3.97%
CUE Cue Biopharma, Inc.
1.0100
-0.98%
INAB IN8bio, Inc.
0.2488
+3.49%
ENTX Entera Bio Ltd.
2.1000
-3.23%
IMUX Immunic, Inc.
1.0000
-3.85%
VCNX Vaccinex, Inc.
1.4100
0.00%
SPRB Spruce Biosciences, Inc.
0.4000
+4.68%
XLO Xilio Therapeutics, Inc.
1.2800
+36.46%